Dividends & Buybacks ·
CDT Equity Inc. effects a 1-for-25 reverse stock split to reduce outstanding shares from approximately 28 million to roughly 1,124,515
CDTCDT Equity Inc.
CDT Equity Inc. filed a certificate of amendment with the Delaware Secretary of State to effectuate a 1-for-25 reverse stock split of its common stock, reducing outstanding shares from approximately 28 million to roughly 1,124,515. The transaction becomes effective on September 28, 2026, at 5:00 p.m. Eastern Time, with adjusted trading expected to commence on September 29, 2026. This action is taken to ensure continued compliance with Nasdaq's bid-price rule for listing maintenance. Fractional shares are not issued; instead, holders receive cash payments based on the closing price on the effective date. CDT Equity Inc. operates in the biopharmaceutical industry, focusing on data-driven drug discovery and therapeutic asset development.